关于开发CHIKV疫苗和确保有需要的国家获得公平的疫苗的战略考虑
Neil Cherian1, Alison Bettis2, Arminder Deol2
1Coalition for Epidemics Preparedness Innovations, Oslo, Norway. neil.cherian@cepi.net.
NPJ vaccines
|August 18, 2023
概括
奇孔古尼亚病毒 (CHIKV) 造成全球健康负担很大. 这篇文章回顾了开发CHIKV疫苗并确保其在全球受影响地区公平分配的努力.
科学领域:
- 病毒学 病毒学
- 流行病学 流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 奇孔古尼亚病毒 (CHIKV) 是一种蚊子传播的树状病毒,在全球范围内引起显著的发病率和死亡率.
- 艾滋病毒感染导致严重的残疾调整寿命年 (DALYs) 损失,全球估计为106,089.
- CHIKV被CEPI认定为优先病原体,并被世卫组织认定为新兴传染病 (EID),突显了急需进行干预的必要性.
研究的目的:
- 概述了疫情准备创新联盟 (CEPI) 在开发奇孔古尼亚疫苗方面的战略努力和考虑.
- 讨论确保在特有国家获得潜在的CHIKV疫苗的公平准入的战略.
主要方法:
- 这篇观点文章回顾了现有的文献和CEPI的战略文件.
- 对全球卫生优先事项和疫苗开发格局的分析.
- 对新兴传染病的公平接入框架的审查.
主要成果:
- 在CHIKV疫苗开发方面取得了重大进展.
- CEPI的战略方法侧重于加速候选疫苗和解决全球卫生需求.
- 公平获取仍然是全球卫生安全的关键考虑因素.
结论:
- 开发一种安全有效的CHIKV疫苗是全球卫生优先事项.
- 战略伙伴关系和公平接入计划对于减轻奇孔古尼亚疫情影响至关重要.
- 持续的投资和合作对于控制CHIKV疫情至关重要.
更多相关视频
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10.5K
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.6K
相关概念视频
01:51Vaccinations
44.7K
Overview
44.7K
01:22Development of Immunocompetence
342
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
342